Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/14571
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.date.accessioned2023-08-08T15:28:03Z-
dc.date.available2023-08-08T15:28:03Z-
dc.date.issued2022-11-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/14571-
dc.description3 p.pt_BR
dc.language.isoporpt_BR
dc.publisherINCA-
dc.relation.ispartofseriesAno VI, n. 67.-
dc.subjectCarcinoma Hepatocelular/diagnósticopt_BR
dc.subjectCarcinoma, Hepatocellular/diagnosispt_BR
dc.subjectCarcinoma Hepatocelular/terapiapt_BR
dc.subjectCarcinoma, Hepatocellular/therapypt_BR
dc.titlePortaria Conjunta n. 18/SAES e SCTIE/MS, de 14 de outubro de 2022pt_BR
dc.TypeOtherpt_BR
Appears in Collections:Informe SUS - ONCO 2022

Files in This Item:
File Description SizeFormat 
informe-sus-onco-novembro_2022_0.pdf457.78 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.